Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Idarubicin and Cladribine in Recurrent and Refractory Acute Myeloid Leukemia: A POG Phase II Study

NCT00003178 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00003178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Idarubicin and Cladribine in Recurrent and Refractory Acute Myeloid Leukemia: A POG Phase II Study
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
March 31, 1998
Completion date
March 31, 2007
Enrollment
120 (actual)
Sites
235

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia